EdgarLookup

CINTAS CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CINTAS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
111.9%
Profit Margin
Net income ÷ revenue
18.4%
Return on Assets
Net income ÷ assets
-10.6%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2020 May 31, 2020 $1.62B Jul 29, 2020
FY2020 Feb 29, 2020 $1.81B Jul 29, 2020
FY2020 Nov 30, 2019 $1.84B Jul 29, 2020
FY2020 Aug 31, 2019 $1.81B Jul 29, 2020
FY2020 May 31, 2019 $1.79B Jul 29, 2020
FY2020 Feb 28, 2019 $1.68B Jul 29, 2020
FY2020 Nov 30, 2018 $1.72B Jul 29, 2020
FY2020 Aug 31, 2018 $1.70B Jul 29, 2020
FY2019 May 31, 2018 $1.67B Jul 26, 2019
FY2019 Feb 28, 2018 $1.59B Jul 26, 2019

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $10.34B Jul 28, 2025
FY2025 May 31, 2024 $9.60B Jul 28, 2025
FY2025 May 31, 2023 $8.82B Jul 28, 2025
FY2024 May 31, 2022 $7.85B Jul 25, 2024
FY2023 May 31, 2021 $7.12B Jul 27, 2023
FY2022 May 31, 2020 $7.09B Jul 27, 2022
FY2021 May 31, 2019 $6.89B Jul 28, 2021
FY2020 May 31, 2018 $6.48B Jul 29, 2020
FY2019 May 31, 2017 $5.32B Jul 26, 2019

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $5.17B Jul 28, 2025
FY2025 May 31, 2024 $4.69B Jul 28, 2025
FY2025 May 31, 2023 $4.17B Jul 28, 2025
FY2024 May 31, 2022 $3.63B Jul 25, 2024
FY2023 May 31, 2021 $3.31B Jul 27, 2023
FY2020 May 31, 2020 $707.82M Jul 29, 2020
FY2020 Feb 29, 2020 $824.40M Jul 29, 2020
FY2020 Nov 30, 2019 $852.39M Jul 29, 2020
FY2020 Aug 31, 2019 $849.14M Jul 29, 2020
FY2020 May 31, 2019 $823.57M Jul 29, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $1.81B Jul 28, 2025
FY2025 May 31, 2024 $1.57B Jul 28, 2025
FY2025 May 31, 2023 $1.35B Jul 28, 2025
FY2024 May 31, 2022 $1.24B Jul 25, 2024
FY2023 May 31, 2021 $1.11B Jul 27, 2023
FY2022 May 31, 2020 $876.04M Jul 27, 2022
FY2021 May 31, 2019 $884.98M Jul 28, 2021
FY2020 May 31, 2018 $842.59M Jul 29, 2020
FY2019 May 31, 2017 $480.71M Jul 26, 2019
FY2018 May 31, 2016 $693.52M Jul 27, 2018

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $2.36B Jul 28, 2025
FY2025 May 31, 2024 $2.07B Jul 28, 2025
FY2025 May 31, 2023 $1.80B Jul 28, 2025
FY2024 May 31, 2022 $1.59B Jul 25, 2024
FY2023 May 31, 2021 $1.39B Jul 27, 2023
FY2022 May 31, 2020 $1.16B Jul 27, 2022
FY2021 May 31, 2019 $1.13B Jul 28, 2021
FY2020 May 31, 2018 $949.83M Jul 29, 2020
FY2019 May 31, 2017 $773.69M Jul 26, 2019
FY2018 May 31, 2016 $768.94M Jul 27, 2018

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $2.81B Jul 28, 2025
FY2025 May 31, 2024 $2.62B Jul 28, 2025
FY2025 May 31, 2023 $2.37B Jul 28, 2025
FY2024 May 31, 2022 $2.04B Jul 25, 2024
FY2023 May 31, 2021 $1.93B Jul 27, 2023
FY2022 May 31, 2020 $2.07B Jul 27, 2022
FY2021 May 31, 2019 $1.98B Jul 28, 2021
FY2020 May 31, 2018 $1.92B Jul 29, 2020
FY2019 May 31, 2017 $1.53B Jul 26, 2019
FY2018 May 31, 2016 $1.33B Jul 27, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $2.17B Jul 28, 2025
FY2025 May 31, 2024 $2.07B Jul 28, 2025
FY2025 May 31, 2023 $1.59B Jul 28, 2025
FY2024 May 31, 2022 $1.54B Jul 25, 2024
FY2023 May 31, 2021 $1.36B Jul 27, 2023
FY2022 May 31, 2020 $1.29B Jul 27, 2022
FY2021 May 31, 2019 $1.07B Jul 28, 2021
FY2020 May 31, 2018 $964.16M Jul 29, 2020
FY2019 May 31, 2017 $763.89M Jul 26, 2019
FY2016 May 31, 2016 $465.85M Jul 29, 2016

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $408.88M Jul 28, 2025
FY2025 May 31, 2024 $409.47M Jul 28, 2025
FY2025 May 31, 2023 $331.11M Jul 28, 2025
FY2024 May 31, 2022 $240.67M Jul 25, 2024
FY2023 May 31, 2021 $143.47M Jul 27, 2023
FY2022 May 31, 2020 $230.29M Jul 27, 2022
FY2021 May 31, 2019 $276.72M Jul 28, 2021
FY2020 May 31, 2018 $271.70M Jul 29, 2020
FY2019 May 31, 2017 $273.32M Jul 26, 2019
FY2018 May 31, 2016 $275.39M Jul 27, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $9.83B Jul 28, 2025
FY2025 May 31, 2024 $9.17B Jul 28, 2025
FY2025 May 31, 2023 $8.55B Jul 28, 2025
FY2024 May 31, 2022 $8.15B Jul 25, 2024
FY2023 May 31, 2021 $8.24B Jul 27, 2023
FY2022 May 31, 2020 $7.67B Jul 27, 2022
FY2021 May 31, 2019 $7.44B Jul 28, 2021
FY2019 Jun 1, 2018 $7.21B Jul 26, 2019
FY2020 May 31, 2018 $6.96B Jul 29, 2020
FY2019 May 31, 2017 $6.84B Jul 26, 2019

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $4.68B Jul 28, 2025
FY2025 May 31, 2024 $4.32B Jul 28, 2025
FY2025 May 31, 2023 $3.86B Jul 28, 2025
FY2025 May 31, 2022 $3.31B Jul 28, 2025
FY2024 May 31, 2021 $3.69B Jul 25, 2024
FY2023 May 31, 2020 $3.24B Jul 27, 2023
FY2022 May 31, 2019 $3.00B Jul 27, 2022
FY2019 Jun 1, 2018 $3.21B Jul 26, 2019
FY2021 May 31, 2018 $3.02B Jul 28, 2021
FY2020 May 31, 2017 $2.30B Jul 29, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $3.40B Jul 28, 2025
FY2025 May 31, 2024 $3.21B Jul 28, 2025
FY2025 May 31, 2023 $3.06B Jul 28, 2025
FY2024 May 31, 2022 $3.04B Jul 25, 2024
FY2023 May 31, 2021 $2.91B Jul 27, 2023
FY2022 May 31, 2020 $2.87B Jul 27, 2022
FY2021 May 31, 2019 $2.84B Jul 28, 2021
FY2020 May 31, 2018 $2.85B Jul 29, 2020
FY2019 May 31, 2017 $2.78B Jul 26, 2019
FY2018 May 31, 2016 $1.28B Jul 27, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $11.80B Jul 28, 2025
FY2025 May 31, 2024 $10.62B Jul 28, 2025
FY2024 May 31, 2023 $9.60B Jul 25, 2024
FY2023 May 31, 2022 $8.72B Jul 27, 2023
FY2022 May 31, 2021 $7.88B Jul 27, 2022
FY2021 May 31, 2020 $7.30B Jul 28, 2021
FY2020 May 31, 2019 $6.69B Jul 29, 2020
FY2019 Jun 1, 2018 $6.03B Jul 26, 2019
FY2019 May 31, 2018 $5.84B Jul 26, 2019
FY2018 May 31, 2017 $5.17B Jul 27, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $263.97M Jul 28, 2025
FY2025 May 31, 2024 $342.02M Jul 28, 2025
FY2024 May 31, 2023 $124.15M Jul 25, 2024
FY2023 May 31, 2022 $90.47M Jul 27, 2023
FY2022 May 31, 2021 $493.64M Jul 27, 2022
FY2021 May 31, 2020 $145.40M Jul 28, 2021
FY2020 May 31, 2019 $96.65M Jul 29, 2020
FY2019 May 31, 2018 $138.72M Jul 26, 2019
FY2018 May 31, 2017 $169.27M Jul 27, 2018
FY2018 May 31, 2016 $139.36M Jul 27, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $2.42B Jul 28, 2025
FY2025 May 31, 2024 $2.03B Jul 28, 2025
FY2024 May 31, 2023 $2.49B Jul 25, 2024
FY2023 May 31, 2022 $2.48B Jul 27, 2023
FY2022 May 31, 2021 $1.64B Jul 27, 2022
FY2021 May 31, 2020 $2.54B Jul 28, 2021
FY2020 May 31, 2019 $2.54B Jul 29, 2020
FY2019 May 31, 2018 $2.54B Jul 26, 2019
FY2018 May 31, 2017 $2.77B Jul 27, 2018
FY2017 May 31, 2016 $1.04B Jul 31, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 4 Jul 28, 2025
FY2025 May 31, 2024 3 Jul 28, 2025
FY2025 May 31, 2023 3 Jul 28, 2025
FY2024 May 31, 2022 11 Jul 25, 2024
FY2023 May 31, 2021 10 Jul 27, 2023
FY2022 May 31, 2020 8 Jul 27, 2022
FY2021 May 31, 2019 8 Jul 28, 2021
FY2020 May 31, 2018 7 Jul 29, 2020
FY2019 May 31, 2017 4 Jul 26, 2019
FY2018 May 31, 2016 6 Jul 27, 2018

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 4 Jul 28, 2025
FY2025 May 31, 2024 3 Jul 28, 2025
FY2025 May 31, 2023 3 Jul 28, 2025
FY2024 May 31, 2022 11 Jul 25, 2024
FY2023 May 31, 2021 10 Jul 27, 2023
FY2022 May 31, 2020 8 Jul 27, 2022
FY2021 May 31, 2019 7 Jul 28, 2021
FY2020 May 31, 2018 7 Jul 29, 2020
FY2019 May 31, 2017 4 Jul 26, 2019
FY2018 May 31, 2016 6 Jul 27, 2018

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 402.95M Jul 28, 2025
FY2025 May 31, 2024 405.01M Jul 28, 2025
FY2024 May 31, 2023 101.73M Jul 25, 2024
FY2023 May 31, 2022 101.71M Jul 27, 2023
FY2022 May 31, 2021 104.06M Jul 27, 2022
FY2021 May 31, 2020 103.42M Jul 28, 2021
FY2020 May 31, 2019 103.28M Jul 29, 2020
FY2019 May 31, 2018 106.33M Jul 26, 2019
FY2018 May 31, 2017 105.40M Jul 27, 2018
FY2017 May 31, 2016 105.40M Jul 31, 2017

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 May 31, 2025 $611.63M Jul 28, 2025
FY2025 May 31, 2024 $530.91M Jul 28, 2025
FY2025 May 31, 2023 $449.92M Jul 28, 2025
FY2024 May 31, 2022 $375.12M Jul 25, 2024
FY2023 May 31, 2021 $451.33M Jul 27, 2023
FY2022 May 31, 2020 $267.96M Jul 27, 2022
FY2021 May 31, 2019 $220.76M Jul 28, 2021
FY2020 May 31, 2018 $175.59M Jul 29, 2020
FY2019 May 31, 2017 $142.43M Jul 26, 2019
FY2018 May 31, 2016 $115.27M Jul 27, 2018